stars 1 stars 2 stars 3

Intezyne is a clinical-stage biotechnology company focused on increasing the effectiveness of cancer treatments through the application of a diverse portfolio of proprietary assets. The Company is currently advancing these assets through various stages of the clinical approval process.

Intezyne Technologies Questions

The Intezyne Technologies annual revenue was $6.5 million in 2026.

Daniel Devers is the CBO of Intezyne Technologies.

1 people are employed at Intezyne Technologies.

Intezyne Technologies is based in Tampa, Florida.

The NAICS codes for Intezyne Technologies are [325, 32541, 3254, 32].

The SIC codes for Intezyne Technologies are [28, 283].

Top Intezyne Technologies Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users